Mast Cell Activation Syndrome
6 clinical trials · Condition
◉ Watch Mast Cell Activation Syndrome
| Record | Firm | Date |
|---|---|---|
| Masitinib for the Treatment of Severe Mast Cell Activation Syndrome (NCT05449444) | AB Science | 2022-07-01 |
| Ocular and Palpebral Manifestations of Mastocytosis (MOOMA) (NCT04978740) | Poitiers University Hospital | 2021-07-30 |
| Mast Cell Activation Test in Allergic Disease (NCT03406325) | Hong Kong Sanatorium & Hospital | 2018-02-01 |
Track Mast Cell Activation Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.